Pneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spectrum Antiviral Drug, at the American Thoracic Society (ATS) 2024 Conference
May 23, 2024 07:00 ET
|
Pneumagen Ltd
Neumifil delivers statistically significant reductions in influenza symptomatic infection rate, symptom severity and viral loadStrategy to advance clinical development of Neumifil to be based on...
Global Pediatric Antibiotics Market to Surpass US$ 7,759.3 Million by 2030, Says Coherent Market Insights (CMI)
September 06, 2022 09:15 ET
|
CMI
Seattle, Sept. 06, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global pediatric antibiotics market is estimated to be valued at US$ 6,478.9 million in 2022 and is expected to...